Icecure Medical
IceCure Medical Ltd, a commercial stage medical device company, researches, develops, and markets cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers ProSense system, a single probe system for the treatment of malignant breast tumors, as well as associated disposables; and IceSense3 syst… Read more
Market Cap & Net Worth: Icecure Medical (ICCM)
Icecure Medical (NASDAQ:ICCM) has a market capitalization of $41.38 Million ($41.38 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #24524 globally and #8451 in its home market, demonstrating a -2.34% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Icecure Medical's stock price $0.60 by its total outstanding shares 68963210 (68.96 Million).
Icecure Medical Market Cap History: 2015 to 2026
Icecure Medical's market capitalization history from 2015 to 2026. Data shows change from $91.34 Million to $41.38 Million (-7.40% CAGR).
Index Memberships
Icecure Medical is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.20 Trillion | 0.00% | #654 of 976 |
|
NASDAQ Composite
IXIC
|
$32.97 Trillion | 0.00% | #2137 of 3165 |
Weight: Icecure Medical's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Icecure Medical Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Icecure Medical's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
23.05x
Icecure Medical's market cap is 23.05 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $91.34 Million | $762.87K | -$3.75 Million | 119.73x | N/A |
| 2016 | $79.39 Million | $625.49K | -$3.27 Million | 126.93x | N/A |
| 2019 | $104.82 Million | $1.66 Million | -$4.76 Million | 63.24x | N/A |
| 2020 | $138.04 Million | $4.08 Million | -$4.78 Million | 33.80x | N/A |
| 2021 | $210.34 Million | $4.14 Million | -$10.07 Million | 50.83x | N/A |
| 2022 | $106.89 Million | $3.08 Million | -$17.22 Million | 34.65x | N/A |
| 2023 | $73.79 Million | $3.23 Million | -$14.65 Million | 22.85x | N/A |
| 2024 | $75.86 Million | $3.29 Million | -$15.32 Million | 23.05x | N/A |
Competitor Companies of ICCM by Market Capitalization
Companies near Icecure Medical in the global market cap rankings as of March 19, 2026.
Key companies related to Icecure Medical by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
Icecure Medical Historical Marketcap From 2015 to 2026
Between 2015 and today, Icecure Medical's market cap moved from $91.34 Million to $ 41.38 Million, with a yearly change of -7.40%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $41.38 Million | -1.64% |
| 2025 | $42.07 Million | -44.54% |
| 2024 | $75.86 Million | +2.80% |
| 2023 | $73.79 Million | -30.97% |
| 2022 | $106.89 Million | -49.18% |
| 2021 | $210.34 Million | +52.38% |
| 2020 | $138.04 Million | +31.68% |
| 2019 | $104.82 Million | +32.04% |
| 2016 | $79.39 Million | -13.08% |
| 2015 | $91.34 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Icecure Medical was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $41.38 Million USD |
| MoneyControl | $41.38 Million USD |
| MarketWatch | $41.38 Million USD |
| marketcap.company | $41.38 Million USD |
| Reuters | $41.38 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.